• South faces growing threat of yellow fever resurgence, experts say

    The spread of mosquito-transmitted viruses is accelerating in the Southern U.S., stirring concerns about the potential return of yellow fever, two infectious disease experts wrote in an Oct. 14 article for The New England Journal of Medicine.
  • A new long COVID-19 theory emerges: Penn Medicine study

    Remnants of the virus that causes COVID-19 may linger in the gut, ultimately causing a reduction in circulating levels of serotonin. This may explain a number of long COVID-19 symptoms, such as brain fog and memory problems, according to new research from scientists at the University of Pennsylvania in Philadelphia.
  • Flu hospitalizations tick up nationwide: 5 FluView notes

    Last week, 1,127 patients with laboratory-confirmed flu cases were admitted to a hospital, according to CDC data ending Oct. 7.
  • Hawaii health officials warn Maui residents to avoid toxic ash

    Following the August wildfires that decimated parts of Maui, the state's department of health issued a new warning Oct. 15 urging the public residents and visitors to avoid contact with toxic ash remnants. 
  • COVID down. RSV, flu up: 4 notes

    New weekly COVID-19 admissions are down for the fourth week straight, according to the latest data from the CDC. Meanwhile, flu and respiratory syncytial virus are starting to rise. 
  • 'We're angry': RSV, COVID shot rollout hits wall

    Health experts are betting on a collection of vaccines and a monoclonal antibody to prevent severe illness and minimize capacity strain on hospitals from flu, COVID-19 and respiratory syncytial virus this respiratory virus season. However, hurdles in accessing the shots may prevent those most at risk for severe illness from getting vaccinated before virus season is in full swing. 
  • New AI tool designed to predict COVID-19 strains

    Researchers at Boston-based Harvard Medical School and University of Oxford in England have created an AI tool to forecast which COVID-19 strains will grow in dominance, according to an Oct. 11 article in Nature. 
  • Avian flu in Seattle mammals concerns health experts

    After seals in Seattle's Puget Sound tested positive for H5N1 avian flu in late August, a researcher at the University of Washington Medical School is highlighting the unprecedented wave of cases in the last year and what that means for human health.
  • Healthcare leaders not confident US is prepared for next pandemic

    Forty percent of healthcare leaders are "not confident at all" that the U.S. would be better prepared for a future pandemic, according to a September Becker's LinkedIn poll.
  • The disease set to 'take off' in Southern US: Reuters

    Dengue fever, an infection caused by mosquito bites, may become increasingly common across the Southern U.S. within the next decade.
  • RSV cases tick up slightly across US

    Cases of respiratory syncytial virus have been rising slowly in the U.S., according to CDC data published Oct. 5.
  • Ohio cancer center gets $20M to study tobacco for FDA

    Columbus-based Ohio State University Comprehensive Cancer Center was awarded $20 million by the Tobacco Center of Regulatory Science to gather evidence needed to inform the FDA's regulation of tobacco products.
  • US to phase out COVID vaccine cards

    The CDC has announced the agency will no longer distribute COVID-19 vaccination cards. 
  • New York City grapples to rein in rising tuberculosis cases

    New York City has already confirmed about 500 cases of active tuberculosis this year, and understaffed clinics have led to long waits for diagnosis and treatment, Politico reported Oct. 4.
  • CDC taps Verily for wastewater surveillance

    Verily, the healthcare unit of parent company Alphabet, has won its first CDC contract to support national wastewater monitoring, the company said Oct. 2. 
  • A flu lineage may have been eliminated: WHO

    There have been no confirmed detections of infections caused by a family of flu viruses known as Influenza B/Yamagata since March 2020, suggesting it may have been eliminated. Based on that, the World Health Organization recommends leaving it out of flu shot compositions for next year. 
  • COVID-19 metrics continue decline: 4 updates

    COVID-19 hospitalizations have fallen for the second week after the U.S. noted a slight uptick every week since July, according to CDC data. 
  • HHS unveils $104M project to combat antibiotic resistance

    HHS is awarding up to $104 million to a project to combat the growing threat of drug-resistant bacteria, which account for nearly 3.8 million infections a year in the U.S. 
  • US adults more likely to get vaccinated for flu vs COVID this fall

    Despite the emergence of new variants and even after weeks of rising COVID-19 hospitalizations nationwide, 40 percent of Americans are not planning to get the new vaccine, according to survey data from the National Foundation for Infectious Diseases.
  • COVID-19 admissions per age group

    The lowest COVID-19 hospitalization rates since the start of the pandemic were recorded in June, and since then, COVID-19 admissions have nearly doubled in the U.S.

Featured Whitepapers

Featured Webinars